Effects of discontinuing a high-fat diet on mitochondrial proteins and 6-hydroxydopamine-induced dopamine depletion in rats

Brain Research

Volumn 1613, Issue , 2015, Pages 49-58

  Ma, Delin ^a,c   Shuler, Jeffrey M ^a   Raider, Kayla D ^a   Rogers, Robert S ^a   Wheatley, Joshua L ^a   Geiger, Paige C ^a   Stanford, John A ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

6 Hydroxydopamine; Dopamine; Obesity

Indexed keywords

6 HYDROXYTRYPTAMINE; ADENYLATE KINASE; BETA ACTIN; DOPAMINE; INSULIN; MITOCHONDRIAL PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEASOME; PROTEIN KINASE B; TRANSCRIPTION FACTOR NRF1; GLUCOSE; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; CONTROLLED STUDY; CORPUS STRIATUM; INSULIN RESISTANCE; LIPID DIET; LOW FAT DIET; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OBESITY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBSTANTIA NIGRA; ADVERSE EFFECTS; ANIMAL; BODY WEIGHT; CHEMICALLY INDUCED; DIET THERAPY; DRUG EFFECTS; FISCHER 344 RAT; MALE; METABOLISM; MOTOR ACTIVITY; PARKINSONISM; RAT;

RATTUS;

ANIMALS; BODY WEIGHT; CORPUS STRIATUM; DIET, FAT-RESTRICTED; DIET, HIGH-FAT; DOPAMINE; GLUCOSE; MALE; MITOCHONDRIAL PROTEINS; MOTOR ACTIVITY; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, INBRED F344; SUBSTANTIA NIGRA;

EID: 84930081694     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2015.03.053     Document Type: Article

References (39)

1. C.A. Altar, M.R. Marien, and J.F. Marshall Time course of adaptations in dopamine biosynthesis, metabolism, and release following nigrostriatal lesions: implications for behavioral recovery from brain injury J. Neurochem. 48 1987 390 399
2. I. Aviles-Olmos, P. Limousin, A. Lees, and T. Foltynie Parkinson's disease, insulin resistance and novel agents of neuroprotection Brain 136 2013 374 384
3. T.J. Bartness, D.R. Polk, W.R. McGriff, T.G. Youngstrom, and M. DiGirolamo Reversal of high-fat diet-induced obesity in female rats Am. J. Physiol. 263 1992 R790 R797
4. C.S. Bethel-Brown, J.K. Morris, and J.A. Stanford Young and middle-aged rats exhibit isometric forelimb force control deficits in a model of early-stage Parkinson's disease Behav. Brain Res. 225 2011 97 103
5. A. Bhat, A. Koul, E. Rai, S. Sharma, M.K. Dhar, and R.N. Bamezai PGC-1alpha Thr394Thr and Gly482Ser variants are significantly associated with T2DM in two North Indian populations: a replicate case-control study Hum. Genet. 121 2007 609 614
6. M. Biswas, and J.Y. Chan Role of Nrf1 in antioxidant response element-mediated gene expression and beyond Toxicol. Appl. Pharmacol. 244 2010 16 20
7. C. Canto, and J. Auwerx PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure Curr. Opin. Lipidol. 20 2009 98 105
8. C. Canto, Z. Gerhart-Hines, J.N. Feige, M. Lagouge, L. Noriega, J.C. Milne, P.J. Elliott, P. Puigserver, and J. Auwerx AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity Nature 458 2009 1056 1060
9. J.S. Choi, C. Park, and J.W. Jeong AMP-activated protein kinase is activated in Parkinson's disease models mediated by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Biochem. Biophys. Res. Commun. 391 2010 147 151
10. J.Y. Choi, E.H. Jang, C.S. Park, and J.H. Kang Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity Free Radical Biol. Med. 38 2005 806 816
11. B. Clodfelder-Miller, P. De Sarno, A.A. Zmijewska, L. Song, and R.S. Jope Physiological and pathological changes in glucose regulate brain Akt and glycogen synthase kinase-3 J. Biol. Chem. 280 2005 39723 39731
12. S. Costes, C.J. Huang, T. Gurlo, M. Daval, A.V. Matveyenko, R.A. Rizza, A.E. Butler, and P.C. Butler beta-cell dysfunctional ERAD/ubiquitin/proteasome system in type 2 diabetes mediated by islet amyloid polypeptide-induced UCH-L1 deficiency Diabetes 60 2011 227 238
13. S. Geisler, S. Vollmer, S. Golombek, and P.J. Kahle The ubiquitin-conjugating enzymes UBE2N, UBE2L3 and UBE2D2/3 are essential for Parkin-dependent mitophagy J. Cell Sci. 127 2014 3280 3293
14. A.A. Gupte, G.L. Bomhoff, J.K. Morris, B.K. Gorres, and P.C. Geiger Lipoic acid increases heat shock protein expression and inhibits stress kinase activation to improve insulin signaling in skeletal muscle from high-fat-fed rats J. Appl. Physiol. 106 2009 1425 1434
15. N. Hariri, and L. Thibault High-fat diet-induced obesity in animal models Nutr. Res. Rev. 23 2010 270 299
16. G. Hu, P. Jousilahti, S. Bidel, R. Antikainen, and J. Tuomilehto Type 2 diabetes and the risk of Parkinson's disease Diabetes Care 30 2007 842 847
17. A. Koch, J. Steffen, and E. Kruger TCF11 at the crossroads of oxidative stress and the ubiquitin proteasome system Cell Cycle 10 2011 1200 1207
18. S.H. Koo, H. Satoh, S. Herzig, C.H. Lee, S. Hedrick, R. Kulkarni, R.M. Evans, J. Olefsky, and M. Montminy PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3 Nat. Med. 10 2004 530 534
19. M.A. Lawlor, and D.R. Alessi PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J. Cell Sci. 114 2001 2903 2910
20. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
21. J.K. Morris, G.L. Bomhoff, J.A. Stanford, and P.C. Geiger Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet Am. J. Physiol. Regul. Integr. Comp. Physiol. 299 2010 R1082 R1090
22. J.K. Morris, H. Zhang, A.A. Gupte, G.L. Bomhoff, J.A. Stanford, and P.C. Geiger Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease Brain Res. 1240 2008 185 195
23. M.C. Myhrstad, C. Husberg, P. Murphy, O. Nordstrom, R. Blomhoff, J.O. Moskaug, and A.B. Kolsto TCF11/Nrf1 overexpression increases the intracellular glutathione level and can transactivate the gamma-glutamylcysteine synthetase (GCS) heavy subunit promoter Biochim. Biophys. Acta 1517 2001 212 219
24. L. Naef, A. Gratton, and C.D. Walker Exposure to high fat during early development impairs adaptations in dopamine and neuroendocrine responses to repeated stress Stress 16 2013 540 548
25. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1998 Academic Press San Diego, CA
26. P. Puigserver, J. Rhee, J. Donovan, C.J. Walkey, J.C. Yoon, F. Oriente, Y. Kitamura, J. Altomonte, H. Dong, D. Accili, and B.M. Spiegelman Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction Nature 423 2003 550 555
27. A. Salminen, K. Kaarniranta, A. Haapasalo, H. Soininen, and M. Hiltunen AMP-activated protein kinase: a potential player in Alzheimer's disease J. Neurochem. 118 2011 460 474
28. J.A. Santiago, and J.A. Potashkin Shared dysregulated pathways lead to Parkinson's disease and diabetes Trends Mol. Med. 19 2013 176 186
29. J. St-Pierre, S. Drori, M. Uldry, J.M. Silvaggi, J. Rhee, S. Jager, C. Handschin, K. Zheng, J. Lin, W. Yang, D.K. Simon, R. Bachoo, and B.M. Spiegelman Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators Cell 127 2006 397 408
30. J. Steffen, M. Seeger, A. Koch, and E. Kruger Proteasomal degradation is transcriptionally controlled by TCF11 via an ERAD-dependent feedback loop Mol. Cell 40 2010 147 158
31. J. Takaya, S. Yamanouchi, and K. Kaneko A calcium-deficient diet in rat dams during gestation and nursing affects hepatic 11beta-hydroxysteroid dehydrogenase-1 expression in the offspring PLoS One 9 2014 e84125
32. J.P. Thaler, C.X. Yi, E.A. Schur, S.J. Guyenet, B.H. Hwang, M.O. Dietrich, X. Zhao, D.A. Sarruf, V. Izgur, K.R. Maravilla, H.T. Nguyen, J.D. Fischer, M.E. Matsen, B.E. Wisse, G.J. Morton, T.L. Horvath, D.G. Baskin, M.H. Tschop, and M.W. Schwartz Obesity is associated with hypothalamic injury in rodents and humans J. Clin. Invest. 122 2012 153 162
33. U. Ungerstedt, and G.W. Arbuthnott Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system Brain Res. 24 1970 485 493
34. A. Wu, Z. Ying, and F. Gomez-Pinilla Oxidative stress modulates Sir2alpha in rat hippocampus and cerebral cortex Eur. J. Neurosci. 23 2006 2573 2580
35. N. Yamamoto, T. Matsubara, K. Sobue, M. Tanida, R. Kasahara, K. Naruse, H. Taniura, T. Sato, and K. Suzuki Brain insulin resistance accelerates Abeta fibrillogenesis by inducing GM1 ganglioside clustering in the presynaptic membranes J. Neurochem. 121 2012 619 628
36. Y. Yang, D. Ma, Y. Wang, T. Jiang, S. Hu, M. Zhang, X. Yu, and C.X. Gong Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes J. Alzheimers Dis. 33 2013 329 338
37. Q. Zhao, Y. Niu, K. Matsumoto, K. Tsuneyama, K. Tanaka, T. Miyata, and T. Yokozawa Chotosan ameliorates cognitive and emotional deficits in an animal model of type 2 diabetes: possible involvement of cholinergic and VEGF/PDGF mechanisms in the brain BMC Complement. Altern. Med. 12 2012 188
38. B. Zheng, Z. Liao, J.J. Locascio, K.A. Lesniak, S.S. Roderick, M.L. Watt, A.C. Eklund, Y. Zhang-James, P.D. Kim, M.A. Hauser, E. Grunblatt, L.B. Moran, S.A. Mandel, P. Riederer, R.M. Miller, H.J. Federoff, U. Wullner, S. Papapetropoulos, M.B. Youdim, I. Cantuti-Castelvetri, A.B. Young, J.M. Vance, R.L. Davis, J.C. Hedreen, C.H. Adler, T.G. Beach, M.B. Graeber, F.A. Middleton, J.C. Rochet, C.R. Scherzer, and P.D.G.E.C. Global PGC-1alpha, a potential therapeutic target for early intervention in Parkinson's disease 52ra73 Sci. Transl. Med. 2 2010
39. C.J. Zuurbier, P.J. Keijzers, A. Koeman, H.B. Van Wezel, and M.W. Hollmann Anesthesia's effects on plasma glucose and insulin and cardiac hexokinase at similar hemodynamics and without major surgical stress in fed rats Anesth. Analg. 106 2008 135 142 table of contents